The CTC offices are currently closed for refurbishment. Access to trial TMFs and patient records will be limited during this period. We will still be able to receive post during this time, but there may be a small delay in responding to this. Our fax lines may also be subject to disruption. Where possible, please direct all correspondence via email to trial-specific email addresses. We appreciate your patience and understanding.

Due to COVID-19 and current government guidance, UCL CTC staff continue to work remotely with limited access to the office. Please continue to email the trial specific mailbox with any urgent queries. For paper CRF trials, please continue to copy and scan CRFs to the trial inboxes (remove all patient identifiers except Trial Number and Initials) until further notice.

Clinical Trials Search

Advanced

Trials portfolio

ABC-07
Addition of stereotactic body radiotherapy to systemic chemotherapy in locally advanced biliary tract cancers

ABC-07 is a multicentre phase II trial, with a 2:1 randomisation between 6 cycles of cisplatin and gemcitabine (CisGem) chemotherapy followed by Stereotactic Body Radiotherapy (SBRT), and 8 cycles Cis [...]

Area: Upper gastro-intestinal cancer

Phase: Phase II

Status: Active (recruiting)

ABC-11
A seamless phase Ib/II study of selective HDAC6 inhibition with KA2507 in advanced biliary tract cancer previously treated with standard of care chemotherapy

Area: Upper gastro-intestinal cancer

Phase: Phase I/II

Status: In set-up (funded)

BTC VTB
Biliary Tract Cancer Virtual Tissue Bank

A series of advanced biliary tract cancer (ABC) trials plan to investigate the value of interventions in addition to CisGem. This portfolio of trials include ABC-02,ABC-03, ABC-06, ABC-07, ACTICCA-1, [...]

Area: Upper gastro-intestinal cancer

Phase: Tissue collection

Status: In follow-up (non-recruiting)

VEROnA
A pilot, open label, single-arm, phase 0, window of opportunity study of vandetanib-eluting radiopaque embolic beads (BTG-002814) in patients with resectable liver malignancies

VEROnA is a pilot, open label, single arm, Phase 0 window of opportunity study of vandetanib eluting radiopaque embolic beads.

Area: Upper gastro-intestinal cancer

Contact Us

Cancer Research UK & UCL Cancer Trials Centre
University College London
90 Tottenham Court Road
London
W1T 4TJ

View map

Email:
ctc.enquiries@ucl.ac.uk
Telephone:
+44 (0)20 7679 9898 (General CTC Enquiries)
Fax:
020 7679 9899

CTC staff

University College London, Gower Street, London, WC1E 6BT +44 (0)20 7679 2000

Copyright © 2021 UCL | Disclaimer | Freedom of Information | Accessibility | Privacy | Cookies | Contact Us